Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.79 is 31% below its 5-year average of 14.20, near the low end of its 5-year range (8.77–28.07).
As of the fiscal period ended Tuesday, June 30, 2026. 20.88% below its 12-month average of 12.37.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.79.
QUICK RATIO (ACID-TEST)
9.79
QUICK RATIO (ACID-TEST) AVG TTM
12.37
QUICK RATIO (ACID-TEST) AVG 3Y
11.79
QUICK RATIO (ACID-TEST) AVG 5Y
14.20
QUICK RATIO (ACID-TEST) AVG 10Y
11.01
QUICK RATIO (ACID-TEST) AVG 15Y
9.22
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-20.88%
CURRENT VS 3Y AVG
-16.97%
CURRENT VS 5Y AVG
-31.02%
CURRENT VS 10Y AVG
-11.10%
CURRENT VS 15Y AVG
+6.14%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 647 covered companies
CURRENT VS SECTOR MEDIAN
+227.47%
vs the sector median at left
Agios Pharmaceuticals, Inc.
Market Cap
$1.88B
Quick Ratio (Acid-Test)
9.79
TTM Avg
12.37
3Y Avg
11.79
5Y Avg
14.20
Market Cap
$1.89B
Quick Ratio (Acid-Test)
7.14
TTM Avg
4.14
3Y Avg
3.11
5Y Avg
3.56
Market Cap
$1.86B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$1.84B
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.57
3Y Avg
2.04
5Y Avg
2.44
Market Cap
$1.82B
Quick Ratio (Acid-Test)
13.96
TTM Avg
11.13
3Y Avg
7.91
5Y Avg
6.39
Market Cap
$1.95B
Quick Ratio (Acid-Test)
2.52
TTM Avg
2.21
3Y Avg
2.25
5Y Avg
2.64
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. (AGIO) | $1.88B | 9.79 | 12.37 | 11.79 | 14.20 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 7.14 | 4.14 | 3.11 | 3.56 |
| Novavax, Inc. (NVAX)vs › | $1.88B | 2.30 | 1.54 | 1.10 | 1.25 |
| Azenta, Inc. (AZTA)vs › | $1.90B | 2.21 | 3.08 | 5.65 | 4.53 |
| Absci Corporation (ABSI)vs › | $1.86B | 10.63 | 5.62 | 5.25 | 6.00 |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 1.23 | 1.57 | 2.04 | 2.44 |
| Novocure Ltd (NVCR)vs › | $1.84B | 2.70 | 2.06 | 4.13 | 5.41 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 13.96 | 11.13 | 7.91 | 6.39 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | 2.52 | 2.21 | 2.25 | 2.64 |
| AxoGen, Inc. (AXGN)vs › | $1.95B | 5.04 | 2.74 | 2.74 | 3.55 |
Quick Ratio
9.79
Excludes inventory
Current Ratio
10.22
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.79 |
| 2026-03-31 | 13.59 |
| 2025-12-31 | 11.06 |
| 2025-09-30 | 13.39 |
| 2025-06-30 | 14.04 |
| 2025-03-31 | 17.93 |
| 2024-12-31 | 11.56 |
| 2024-09-30 | 8.77 |
| 2024-06-30 | 9.71 |
| 2024-03-31 | 12.39 |
| 2023-12-31 | 11.99 |
| 2023-09-30 | 11.76 |
| 2023-06-30 | 13.45 |
| 2023-03-31 | 17.30 |
| 2022-12-31 | 13.16 |
| 2022-09-30 | 14.55 |
| 2022-06-30 | 17.89 |
| 2022-03-31 | 21.24 |
| 2021-12-31 | 17.79 |
| 2021-09-30 | 22.55 |
| 2021-06-30 | 28.07 |
| 2021-03-31 | 24.40 |
| 2020-12-31 | 6.74 |
| 2020-09-30 | 9.43 |
| 2020-06-30 | 12.98 |
| 2020-03-31 | 8.27 |
| 2019-12-31 | 6.51 |
| 2019-09-30 | 5.24 |
| 2019-06-30 | 5.91 |
| 2019-03-31 | 6.86 |
| 2018-12-31 | 6.55 |
| 2018-09-30 | 8.20 |
| 2018-06-30 | 8.88 |
| 2018-03-31 | 13.59 |
| 2017-12-31 | 6.21 |
| 2017-09-30 | 6.01 |
| 2017-06-30 | 6.47 |
| 2017-03-31 | 6.15 |
| 2016-12-31 | 6.73 |
| 2016-09-30 | 7.70 |
| 2016-06-30 | 7.20 |
| 2016-03-31 | 7.31 |
| 2015-12-31 | 6.38 |
| 2015-09-30 | 8.65 |
| 2015-06-30 | 8.63 |
| 2015-03-31 | 12.82 |
| 2014-12-31 | 5.89 |
| 2014-09-30 | 7.17 |
| 2014-06-30 | 5.58 |
| 2014-03-31 | 5.06 |
| 2013-12-31 | 4.60 |
| 2013-09-30 | 5.32 |
| 2013-06-30 | 2.77 |
| 2013-03-31 | 3.20 |
| 2012-12-31 | 3.71 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.00 |
